PINK

Perimeter Medical Imaging AI Announces Webinar Featuring AI Expert, Anantha Kancherla, Discussing Trends in the Use of Machine Learning and Artificial Intelligence in Healthcare Applications

Retrieved on: 
Tuesday, April 16, 2024
Electrical engineering, University, Innovation, UI, Computer science, Perimeter, OTC, Cypress Semiconductor, Meta, Graphics, Artificial intelligence, Fireside chats, Intelligence, DirectX, Lyft, Microsoft, PINK, Bachelor, Marketing, Cypress, General Motors, Computer science and engineering, Ananta, Engineering

With this in mind, Perimeter has built world-class leadership on its Board, the management team, and the engineering department.

Key Points: 
  • With this in mind, Perimeter has built world-class leadership on its Board, the management team, and the engineering department.
  • This webinar showcases the depth of Perimeter's knowledge to apply machine learning models and artificial intelligence tools to our pipeline of products – both existing and still in development.
  • Title: Trends in Artificial Intelligence (AI) and Innovators in Healthcare: Fireside Chat with Perimeter Medical Imaging AI
    Anantha Kancherla is vice president of advanced driver-assistance systems at GM Motors.
  • Prior to Meta, as VP of Engineering at Lyft, Anantha led the Level5 software team responsible for building the self-driving car.

BBX Capital, Inc. Reports Financial Results For the Fourth Quarter and Full Year of 2023

Retrieved on: 
Friday, March 15, 2024
Other Consumer, Food, Beverage, Home Goods, Retail, Urban Planning, Family, Finance, Online Retail, Interior Design, Consumer, Luxury, Other Construction & Property, Professional Services, Residential Building & Real Estate, Commercial Building & Real Estate, Construction & Property, Vacation, Lodging, Travel, Tax, Renin, BVH, Sale, BBX, Investment, OTCQX, PINK, Treasury, Balance sheet, Total

BBX Capital, Inc. (OTCQX: BBXIA) (PINK: BBXIB) (“BBX Capital” or the “Company”) reported today its financial results for the fourth quarter and year ended December 31, 2023.

Key Points: 
  • BBX Capital, Inc. (OTCQX: BBXIA) (PINK: BBXIB) (“BBX Capital” or the “Company”) reported today its financial results for the fourth quarter and year ended December 31, 2023.
  • Selected highlights of BBX Capital’s consolidated financial results include:
    Total consolidated revenues of $96.1 million vs. $107.6 million
    Net loss attributable to shareholders of $(12.9) million vs. net income attributable to shareholders of $15.4 million
    Diluted loss per share of $(0.88) vs. diluted earnings per share of $0.99
    Year Ended December 31, 2023 Compared to the Year Ended December 31, 2022
    Total consolidated revenues of $401.3 million vs. $342.0 million
    Loss before income taxes of $(21.7) million vs. income before income taxes of $42.8 million
    Net loss attributable to shareholders of $(20.8) million vs. income attributable to shareholders of $28.0 million
    Balance Sheet as of December 31, 2023
    Securities available for sale of $44.6 million (primarily U.S. Treasury and federal agency securities with maturities of less than one year)
    Note receivable from Bluegreen Vacations Holding Corporation (NYSE: BVH) of $35.0 million (1)
    The outstanding balance of the note receivable was prepaid in full in January 2024.
  • Fully diluted book value per share is shareholders’ equity divided by the number of BBX Capital’s Class A and Class B common shares and unvested restricted stock awards outstanding on December 31, 2023.
  • For more complete and detailed information regarding BBX Capital and its financial results, business, operations, investments, and risks, including the results of BBX Capital Real Estate, BBX Sweet Holdings, and Renin, please see BBX Capital’s Annual Report on Form 10-K for the year ended December 31, 2023, which is available on the SEC's website, https://www.sec.gov , and on BBX Capital’s website, www.BBXCapital.com .

Perimeter Medical Imaging AI Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update

Retrieved on: 
Thursday, March 28, 2024
OCT, Growth, International, International Financial Reporting Standards, Mayo Clinic, University, AI, Software, Clinical trial, OTC, S series, Breast cancer, IAS, PINK, Perimeter

TORONTO and DALLAS, March 28, 2024 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – today reported financial results for the quarter and year ended December 31, 2023 and provided a corporate update.

Key Points: 
  • TORONTO and DALLAS, March 28, 2024 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – today reported financial results for the quarter and year ended December 31, 2023 and provided a corporate update.
  • Mr. Mendes continued, "As we enter 2024, patient enrollment is outpacing our original projections for our pivotal clinical trial.
  • In addition, our pipeline of product innovations is growing, with several new product introductions and AI enhancements anticipated this year.
  • The Company will host a conference call and live audio webcast today at 4:30 pm Eastern Time to discuss its fourth quarter and year-end 2023 results and provide a corporate update.

Perimeter Medical Imaging AI Provides Corporate Update on Grant Funding Opportunities and Announces Conference Call/Webcast to Discuss Fourth Quarter and Year-End 2023 Financial Results

Retrieved on: 
Wednesday, March 20, 2024
OCT, PSI, Webcast, Society, Surgeon, Clinical trial, OTC, Surgical oncology, PINK, Perimeter, DARPA, Pharmaceutical industry

DALLAS and TORONTO, March 20, 2024 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – announced upcoming events and provided a corporate update on grant funding opportunities to support its next-generation AI technology development.

Key Points: 
  • DALLAS and TORONTO, March 20, 2024 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – announced upcoming events and provided a corporate update on grant funding opportunities to support its next-generation AI technology development.
  • Although disappointing, it's important to note that these funds were proposed for future tissue type investigations and related product development.
  • We look forward to providing a more detailed corporate update when we announce our year-end 2023 results next week."
  • A telephonic playback of the conference call will be available for 14 days after the conference call by calling 1-844-512-2921 or 1-412-317-6671 and referencing conference ID 62216896.

Victoria’s Secret & Co. Reports Fourth Quarter 2023 Results

Retrieved on: 
Wednesday, March 6, 2024
Acquisition, Forecasting, Share repurchase, Marketing, Growth, PINK, Adore Me, Health, GAAP, VSCO, ABL, Video game

REYNOLDSBURG, Ohio, March 06, 2024 (GLOBE NEWSWIRE) -- Victoria’s Secret & Co. (“Victoria’s Secret” or the “Company”) (NYSE: VSCO) today reported 2023 financial results for the fourth quarter and fiscal year ended February 3, 2024.

Key Points: 
  • REYNOLDSBURG, Ohio, March 06, 2024 (GLOBE NEWSWIRE) -- Victoria’s Secret & Co. (“Victoria’s Secret” or the “Company”) (NYSE: VSCO) today reported 2023 financial results for the fourth quarter and fiscal year ended February 3, 2024.
  • This result compares to net income of $173 million, or $2.10 per diluted share for the 13-week fourth quarter of 2022.
  • Fourth quarter 2023 operating income was $258 million compared to operating income of $243 million in the fourth quarter of 2022.
  • Fourth quarter 2022 adjusted net income was $203 million, or $2.47 per diluted share, and adjusted operating income was $280 million.

Perimeter Medical Imaging AI Reports Its Proprietary Artificial Intelligence Algorithm + OCT Identified 96.8% of Positive Breast Cancer Margins in Newly Published Peer Reviewed Study

Retrieved on: 
Thursday, February 29, 2024
Breast cancer, Perimeter, Baylor University, Neoplasm, Fusion, OTC, PINK, Principal investigator, Data, Breast, Medicine, Medical imaging

2023; 13(12):2340. https://doi.org/10.3390/life13122340

Key Points: 
  • 2023; 13(12):2340. https://doi.org/10.3390/life13122340
    From a clinical perspective, the deep learning model showed high levels of sensitivity and specificity, accurately identifying 96.8% of pathology-positive margins.
  • These results highlight the clinical viability of AI-enhanced margin visualization using WF-OCT in breast cancer surgery and its potential to decrease reoperation rates due to residual tumors.
  • Adrian Mendes, Perimeter's Chief Executive Officer, stated, "We have a training dataset of several million proprietary images of both cancerous and healthy tissue captured with our OCT imaging technology.
  • Perimeter intends to conduct a planned interim analysis in the second quarter of 2024, with study completion anticipated by the end of 2024.

Perimeter Medical Imaging AI Announces Publication of Peer-Reviewed Research Examining the High Rates of Re-Operations Following Breast-Conserving Surgeries and the Associated Increased Healthcare Costs

Retrieved on: 
Tuesday, February 20, 2024
Woman, Perimeter, BCS, University, OTC, Surgeon, PINK, Surgical oncology, Risk, MD Anderson Cancer Center, Attention, PMID, Medicare, Mastectomy, Conversion, Patient, Research

The results of our study demonstrate that high reoperation rates after breast-conserving surgery persist and are correlated with elevated risks and adverse outcomes for patients.

Key Points: 
  • The results of our study demonstrate that high reoperation rates after breast-conserving surgery persist and are correlated with elevated risks and adverse outcomes for patients.
  • I believe that these data underscore the need for new approaches to address high reoperation rates, including better methods of margin assessment for surgeons."
  • Funding to support this research was provided, in part, by Perimeter Medical Imaging AI, Inc.
    1 Kim Y, Ganduglia-Cazaban C, Tamirisa N, Lucci A, Krause TM.
  • Contemporary Analysis of Reexcision and Conversion to Mastectomy Rates and Associated Healthcare Costs for Women Undergoing Breast-Conserving Surgery.

Perimeter Medical Imaging AI Announces Expanded Commercial Presence within National Healthcare Provider System with Follow-On Placement of Perimeter S-Series OCT at Additional Hospital Site

Retrieved on: 
Wednesday, February 7, 2024
Optical coherence tomography, MRI, OTC, Patient, S series, OCT, PINK, Perimeter

DALLAS and TORONTO, Feb. 7, 2024 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – today announced further commercial expansion within a major national healthcare system, with a follow-on placement of its flagship Perimeter S-Series OCT system at a new hospital site in North Texas.

Key Points: 
  • DALLAS and TORONTO, Feb. 7, 2024 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – today announced further commercial expansion within a major national healthcare system, with a follow-on placement of its flagship Perimeter S-Series OCT system at a new hospital site in North Texas.
  • Adrian Mendes, Perimeter's Chief Executive Officer, stated, "Our continued expansion within a major national healthcare system further validates our belief that our surgeon customers recognize the value of Perimeter S-Series in their ORs and the potential benefits to their patients.
  • Combining a surgeon's clinical expertise with OCT technology has the potential to reduce repeat surgeries due to cancer left behind, and we believe Perimeter's innovative technology can become the standard of care in cancer surgery."
  • Perimeter's flagship product, the S-Series OCT (Optical Coherence Tomography), is a pioneering medical imaging system that provides cross-sectional, real-time margin visualization of excised tissue specimens in the operating room at 10 times higher image resolution than X-ray and ultrasound, and 100 times greater image resolution than MRI.

EQS-News: AUSTRIACARD HOLDINGS: A strong multinational technology company in payments & digital security

Retrieved on: 
Tuesday, January 30, 2024
UniCredit, Central bank, Information management, Athens Exchange, Depreciation, Tax, TAG, Data management, System, Interest, PINK, History, Growth, Acquisition, Printing, ADJ, Share repurchase, Security (finance)

Since 1982 and the beginning of its radical business transformation, the company has been constantly growing and gradually transforming into a thriving multinational company with a global reach and an international business footprint.

Key Points: 
  • Since 1982 and the beginning of its radical business transformation, the company has been constantly growing and gradually transforming into a thriving multinational company with a global reach and an international business footprint.
  • In this continuous growth path, a key milestone for the company was in 2007, when it proceeded with the acquisition of AUSTRIACARD from the Central Bank of Austria, a company that supplied Austrian banks with bank cards and their operating system.
  • As a result of AUSTRIACARD HOLDINGS' growth extroversion and good management, impressive financial performance has been achieved in recent years.
  • EBITDA) increased at a cumulative annual growth rate of 31.0%, from €10.2 million to €39.4 million, and Adjusted Earnings Before Taxes (Adj.

Victoria’s Secret & Co. to Create New AI-Powered Shopping Experiences with Google Cloud

Retrieved on: 
Thursday, January 11, 2024
Cloud, Life, NRF, Partnership, PINK, Breast cancer, VS, Secrecy, Mastectomy, Marketing, Google Cloud, Google Workspace, Sales

Victoria’s Secret & Co. will leverage Google Cloud’s AI and generative AI technologies to create more personalized and inclusive online shopping experiences for its global customers.

Key Points: 
  • Victoria’s Secret & Co. will leverage Google Cloud’s AI and generative AI technologies to create more personalized and inclusive online shopping experiences for its global customers.
  • Through this partnership, VS&Co will also leverage Google Cloud’s AI technologies to improve customer and associate experiences and drive operational efficiencies within the business.
  • With Victoria’s Secret & Co.’s website now driving more than 500 million annual visits and growing, a key priority for the company is to leverage new technologies to create personalized customer experiences at scale.
  • Under the new, multi-year partnership, the brand will explore a new generative AI-powered conversational assistant, created with Google Cloud’s AI platform, Vertex AI.